Key point of clinical research protocol design -- management of adverse event in post-marketing drug evaluation曾宪涛, 朱婷婷, 孟详喻, 田国祥520-522
A summarization of systematic review methodology for qualitative dataZHANG Jing-yi, ZHANG Ya-ting, GAI Qiong-yan, ZHAO Xue, WANG Hui-ying, BAI Zheng-gang523-527
Meta - analysis of trimexazine combined with Shexiang Baoxin pills in the treatment of unstable angina pectorisJIANG Feng-bo, LIN Xin-duo, JIA Jia, XU Xiang-lei, LIU Bing528-531,538
Effectiveness and safety of indobufen in preventing cardiovascular and cerebrovascular events: a Meta-analysisXU Rong-bin, YANG Jun, HAN Sheng, SUN Feng, MA Jun532-538
The effects of strength statins in the prevention of contrast induced nephropathy after percutaneous coronary intervention or coronary angiography in the elder patients: a meta-analysisLI Kai-yong, CAO Ye-xuan, ZHANG Shi-qin, LIU Zi-ming, DING Shi-lan-ying, WAN Jing.539-544,555
Effects of abnormal circadian rhythm of blood pressure on prognosis of patients with dilated cardiomyopathyYUAN Lin, TIAN Yi-lun, NIE Shao-ping545-549
Correlation between cystatin C and severity of coronary artery lesions in patients with suspected coronary heart diseaseLV Lv, LIU Hong-bin, TIAN Hong-zhen, YANG Jun-jie, LIU Fei550-552
Changes of metabolites before and after percutaneous coronary intervention in patients with coronary heart diseaseCUI Song, LI Ke-feng, LIU Jing-hua, SONG Xian-tao, LV Shu-zheng553-555
Effect of tirofiban route and timing on intraoperative no - reflow in patients with acute myocardial infarctionLIU Ji-wen, TANG Zeng-yao, WANG Xin-wang, LIU Yu-lian, ZENG Zi-wei, ZHU Bao-cheng, QIAO Ling-wei556-558,562
